- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Astrazeneca Regulatory News (AZN)
Regulatory News for Astrazeneca (AZN)
| Share Price: 3,436.50 | Bid: 3,436.00 | Ask: 3,437.50 | Change: 10.00 (+0.29%) |  | ||||||
| ||||||||||
Transaction in Own Shares
Wed, 11th Jul 2012 07:00
RNS Number : 3667H
AstraZeneca PLC
11 July 2012
?
REPURCHASE OF SHARES IN ASTRAZENECA PLC
Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 25 June 2012 to 3 August 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 457,568 ordinary shares of AstraZeneca PLC at a price of 2913 pence per share on 10 July 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,255,838,437.
A C N Kemp
Company Secretary
11 July 2012
This information is provided by RNS
The company news service from the London Stock Exchange
| Date | Source | Headline | Category |
|---|---|---|---|
| 14-May-13 14:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 08-May-13 14:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 08-May-13 14:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 02-May-13 13:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 01-May-13 15:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 01-May-13 14:00 | RNS | Total Voting Rights | Holding(s) in Company |
| 29-Apr-13 15:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 29-Apr-13 15:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 25-Apr-13 17:50 | RNS | Result of AGM | Results and Trading Reports |
| 25-Apr-13 07:00 | RNS | 1st Quarter Results | Results and Trading Reports |
| 24-Apr-13 09:00 | RNS | Notice of Results | Advance Notice of Results |
| 05-Apr-13 07:00 | RNS | Top-line results from OSKIRA-1 phase III study | Company Announcement - General |
| 03-Apr-13 16:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 03-Apr-13 16:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 02-Apr-13 16:00 | RNS | Total Voting Rights | Holding(s) in Company |
| 02-Apr-13 14:00 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 02-Apr-13 07:00 | RNS | US court says one PULMICORT patent invalid | Company Announcement - General |
| 27-Mar-13 14:30 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 27-Mar-13 14:30 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 26-Mar-13 15:13 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 26-Mar-13 07:00 | RNS | Filing of Annual Report on Form 20-F with SEC | Results and Trading Reports |
| 25-Mar-13 11:38 | RNS | Annual Financial Report | Results and Trading Reports |
| 25-Mar-13 07:00 | RNS | AstraZeneca settles over Crestor patent | Company Announcement - General |
| 21-Mar-13 07:00 | RNS | AstraZeneca announces agreement with Moderna | Company Announcement - General |
| 21-Mar-13 07:00 | RNS | AstraZeneca partners Karolinska Institute | Company Announcement - General |
| 21-Mar-13 07:00 | RNS | AstraZeneca outlines growth strategy | Company Announcement - General |
| 18-Mar-13 13:00 | RNS | AstraZeneca to establish strategic R&D centres | Company Announcement - General |
| 14-Mar-13 10:00 | RNS | Block Listing Application | Company Announcement - General |
| 05-Mar-13 07:00 | RNS | Australian court holds crestor patents invalid | Company Announcement - General |
| 01-Mar-13 16:00 | RNS | Total Voting Rights | Holding(s) in Company |
Regulatory news is displayed end of day, each day at 19:00.
